In the financial year 2017/18 we generated consolidated sales totalling CHF 466.1 million (previous year: CHF 389.6 million). Compared with the previous year, this represents an increase in sales of 19.7 %. The operating results (EBIT) increased by 10.4 % compared to the previous year, from CHF 55.3 million to CHF 61.1 million. Profitability at the EBIT level is 13.1 % (previous year: 14.2 %). The financial year is burdened by the costs of the launch activities and amortisations for our mylife™ YpsoPump® insulin pump totalling CHF 18.0 million (1st half-year 2017/18: CHF 7.5 million). In the reporting period, we achieved sales growth in all segments. Net profit now stands at CHF 52.1 million (previous year: 46.2 million).
Download reports and fact sheets
On this page you can download all financial publications of Ypsomed Holding AG covering the last five years of business activity. If you prefer a printed copy, please use the order form on this page.